Skip to content

Autoimmune and Metabolic Diseases Group


Understanding the mechanisms involved in the maintenance of homeostatic immune responses as well as those that have gone awry in disease states, poses a significant challenge. At the NIBN, a robust platform technology called “direct evolution" is being used to generate superior, soluble anti-inflammatory proteins to treat auto-immune diseases such as psoriasis, rheumatoid arthritis (RA), inflammatory bowel disease (IBD) and asthma. Additionally, this group's efforts include understanding how chronic stress is associated with increased susceptibility to auto-immune disease. Other activities include the role of adipose tissue dysfunction in obesity and associated co-morbidities as well as the relationship between type-2 diabetes, suppression of mitochondrial turnover, -cell dysfunction and apoptosis



 Group members